Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chehrazi, B. B.
Right arrow Articles by Joy, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chehrazi, B. B.
Right arrow Articles by Joy, R. M.

Stroke, Vol 20, 217-224, Copyright © 1989 by American Heart Association


ARTICLES

Prostaglandins and vasoactive amines in cerebral vasospasm after aneurysmal subarachnoid hemorrhage

BB Chehrazi, S Giri and RM Joy
Department of Neurological Surgery, School of Medicine, University of California, Davis, Sacramento 95817.

Five consecutively admitted patients with aneurysmal subarachnoid hemorrhage were treated with an indwelling lumbar spinal catheter. Daily samples of cerebrospinal fluid were analyzed for erythrocyte, protein, glucose, dopamine, epinephrine, serotonin, 5- hydroxyindoleacetic acid, tryptophan, histamine, thromboxane, 6- ketoprostaglandin F1 alpha, prostaglandin E, and prostaglandin F2 alpha concentrations. The patients' neurologic grade on admission, hospital course, presence of vasospasm, level of consciousness, computed tomographic and angiographic findings, and outcome were compared with the concentrations of the above substances in the cerebrospinal fluid. All patients had elevated concentrations of serotonin, with the highest levels found early in the hospital course of the patients who developed vasospasm. Tryptophan content increased markedly in association with clinical and angiographic vasospasm. Concentrations of prostaglandin F2 alpha correlated highly with development of and fluctuations in clinical vasospasm, with angiographic findings, with neurologic grade on admission, and with outcome. Our results suggest that prostaglandin F2 alpha may be involved in delayed clinical vasospasm in patients with subarachnoid hemorrhage.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Kim, J. Han, and E. Kim
Effects of prostaglandin F2alpha on membrane currents in rabbit middle cerebral arterial smooth muscle cells
Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H1018 - H1027.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Oliveira-Filho, M. A. Ezzeddine, A. Z. Segal, F. S. Buonanno, Y. Chang, C. S. Ogilvy, G. Rordorf, L. H. Schwamm, W. J. Koroshetz, and C. T. McDonald
Fever in subarachnoid hemorrhage: Relationship to vasospasm and outcome
Neurology, May 22, 2001; 56(10): 1299 - 1304.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. A. Yakubu and C. W. Leffler
Regulation of ET-1 biosynthesis in cerebral microvascular endothelial cells by vasoactive agents and PKC
Am J Physiol Cell Physiol, February 1, 1999; 276(2): C300 - C305.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Suzuki, K. Kanamaru, M. Kuroki, H. Sun, S. Waga, T. Miyazawa, and R. L. Macdonald
Effects of Tirilazad Mesylate on Vasospasm and Phospholipid Hydroperoxides in a Primate Model of Subarachnoid Hemorrhage • Editorial Comment
Stroke, February 1, 1999; 30(2): 450 - 456.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. F. Villa and A. Gorini
Pharmacology of Lazaroids and Brain Energy Metabolism: A Review
Pharmacol. Rev., March 1, 1997; 49(1): 99 - 136.
[Abstract] [Full Text] [PDF]